Juraj Maďarič
A5041650711- Peripheral Artery Disease Management
- Venous Thromboembolism Diagnosis and Management
- Angiogenesis and VEGF in Cancer
- Aortic aneurysm repair treatments
- Renal and Vascular Pathologies
- Cerebrovascular and Carotid Artery Diseases
- Vascular Procedures and Complications
- Cardiac, Anesthesia and Surgical Outcomes
- Diabetic Foot Ulcer Assessment and Management
- Diagnosis and Treatment of Venous Diseases
- Atrial Fibrillation Management and Outcomes
- Mesenchymal stem cell research
- Biomedical Ethics and Regulation
- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- MRI in cancer diagnosis
- Cardiac pacing and defibrillation studies
- Advanced X-ray and CT Imaging
- Central Venous Catheters and Hemodialysis
- Cardiac electrophysiology and arrhythmias
- Aortic Disease and Treatment Approaches
- Abdominal vascular conditions and treatments
- Transplantation: Methods and Outcomes
- Hemodynamic Monitoring and Therapy
- Cardiac and Coronary Surgery Techniques
National Institute of Cardiovascular Diseases
2015-2025
Comenius University Bratislava
2020-2025
Slovak Medical University
2012-2017
National Institute of Cardiovascular Diseases
2014
Onze Lieve Vrouwziekenhuis Hospital
2005-2008
Flanders Environment Agency
2007
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their dating.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use care therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical judgment, as...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
c It is recommended that recognition be given patients with PAD have a high risk of vascular events in other beds.(Evidence Level A), and as such these should always considered for further events.(Level A, class I) 12 In PAD, it optimization treatment the concomitant coronary artery disease cardiac failure undertaken.(Evidence B, renal failure, attention paid to presence arteriosclerosis (atherosclerosis plus calcification) lower limb, this patient population has poorer prognosis.(Evidence...
[2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with European Society for Vascular Surgery (ESVS)]
The VOYAGER PAD trial (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) demonstrated superiority rivaroxaban plus aspirin versus to reduce major cardiac and ischemic limb events after lower extremity revascularization. Clopidogrel is commonly used as a short-term adjunct endovascular Whether clopidogrel modifies the efficacy safety has not been described.VOYAGER was phase 3, international, double-blind,...
Abstract All guidelines worldwide strongly recommend exercise as a pillar of the management patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy in this setting presents different modalities, and structured programme provides optimal results. This clinical consensus paper is intended for clinicians to promote assist set-up comprehensive programmes best advice with symptomatic chronic PAD. Different training protocols specific PAD are presented. Data on...
A ratio of distal renal pressure to aortic (P(d)/P(a)) <0.90 can be considered a threshold for defining significant artery stenosis (RAS). The aim this study was compare angiography (QRA) and colour duplex ultrasound (CDUS) measurements in assessing RAS.In 56 RAS, percent diameter (DS(angio)), minimal luminal (MLD), Doppler-derived peak systolic velocity (PSV), end-diastolic (EDV), renal-to-aortic (RAR) were obtained compared with the P(d)/P(a) measured 0.014" wire. correlated angiography-...
Stem cell therapy has been proposed to be an alternative in patients with critical limb ischemia (CLI), not eligible for endovascular or surgical revascularization. We compared the therapeutic effects of intramuscular (IM) and intra-arterial (IA) delivery bone marrow cells (BMCs) investigated factors associated benefits. Forty-one (mean age, 66 ± 10 years; 35 males) advanced CLI (Rutherford category, 5 6) revascularization were randomized treatment 40 ml BMCs using local IM ( n = 21)...
All guidelines worldwide strongly recommend exercise as a pillar in the management of patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy this setting presents different modalities, and structured programme provides optimal results. This clinical consensus paper is intended to promote assist set up comprehensive programmes best advice for with symptomatic chronic PAD. Different training protocols specific PAD are presented. Data on patient assessment...
With an increasing global burden of patients with chronic peripheral artery disease (PAD) the safe and effective provision lower limb revascularisation is a growing medical need. Endovascular procedures for treatment PAD have become crucial cornerstone modern vascular medicine, first line approach if technically feasible taking patient choice into consideration. age number comorbidities open surgery also often not feasible. We outline framework key messages, endorsed by board European...
AbstractAll guidelines worldwide strongly recommend exercise as a pillar in the management of patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy this setting presents different modalities, and structured programme provides optimal results. This clinical consensus paper is intended to promote assist set up comprehensive programmes best advice for with symptomatic chronic PAD. Different training protocols specific PAD are presented. Data on patient...
Exercise-induced mitral regurgitation (MR) bears a poor prognosis in patients with congestive heart failure (CHF). Cardiac resynchronization therapy (CRT) is associated improved clinical outcome but its effects on exercise-induced MR remain undetermined. We investigated serial changes functional relation to left ventricular (LV) remodelling and cardiopulmonary performance after CRT.Twenty-eight CHF (LV ejection fraction 25 +/- 7%), broad QRS complex (171 27 ms), at least mild [effective...
Abstract Background The present study investigated factors associated with therapeutic benefits after autologous bone marrow cell (BMC) therapy in patients “no-option” critical limb ischemia (CLI). Methods and results Sixty-two advanced CLI (Rutherford category 5 or 6) not eligible for revascularization were randomized to treatment 40 ml of BMCs (SmartPreP2) by local intramuscular ( n = 32) intra-arterial 30) application. primary endpoint was salvage wound healing at 12 months. Seven (11 %)...
Summary: Post-thrombotic syndrome (PTS) is a chronic venous insufficiency manifestation following an episode of deep-vein thrombosis (DVT). It important and frequent long-term adverse event proximal DVT affecting 20–50% patients. This position paper integrates data guiding clinicians in deciding PTS diagnosis, treatment follow-up.
BackgroundApplication of autologous bone marrow mononuclear cells to "no option" patients with advanced critical limb ischemia (CLI) prevented major amputation in 73% during the 6-month follow-up. We examined which properties stromal also known as bone-marrow derived mesenchymal stem responding and non-responding are important for amputation-free survival. Methods FindingsMesenchymal 41 CLI unsuitable revascularisation were isolated from concentrate used their treatment. Based on clinical...
Chronic critical lower limb ischemia (CLI) has been defined as that endangers the leg. An attempt was made to give a precise definition of CLI, based on clinical and hemodynamic data (Second European Consensus). CLI may be easily from point view rest pain distal foot or gangrene ulceration. It is probably useful add leg ulcers other origin which do not heal because severe ischemia, consider impact frailty adverse outcome. From viewpoint there no consensus most existing classifications are...
The optimal first line management of patients with symptomatic chronic lower extremity peripheral artery disease (PAD) includes secondary prevention cardiovascular risk factors, pharmacological treatment, and supervised exercise therapy (SET). SET programs have shown to be effective in improving walking performance, functional quality life. However, despite a large body evidence, national international guidelines recommending as therapy, remains largely underused PAD. This position paper...